NDAINTRAVENOUSINJECTABLE
Approved
Jul 2001
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
6
Mechanism of Action
Ultrasound Contrast Activity
Pharmacologic Class:
Contrast Agent for Ultrasound Imaging
Clinical Trials (5)
An Ascending Dose Comparison of MVT-100 to Definity in Healthy Volunteers
Started Apr 2019
DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
Started Dec 2018
DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
Started Oct 2018
A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure
Started Jul 2009
Retrospective Safety Study to Compare Mortality in Intensive Care Unite (ICU) Patients Undergoing Echocardiography With or Without DEFINITY®
Started Jun 2008
Loss of Exclusivity
LOE Date
May 4, 2037
136 months away
Patent Expiry
May 4, 2037